1. Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits Izzo, Nicholas J.; Staniszewski, Agnieszka; To, Lillian; Fa, Mauro; Teich, Andrew Franklin; Saeed, Faisal; Wostein, Harrison; Walko III, Thomas; Vaswani, Anisha; Wardius, Meghan; Ravenscroft, Jessica; Mozzoni, Kelsie; Silky, Colleen; Rehak, Courtney; Yurko, Raymond; Finn, Patricia; Look, Gary; Rishton, Gilbert; Safferstein, Hank; Miller, Miles; Johanson, Conrad; Stopa, Edward; Windisch, Manfred; Hutter-Paier, Birgit; Shamloo, Mehrdad; Arancio, Ottavio; LeVine III, Harry; Catalano, Susan M. 2014 Articles Neurosciences